Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all

NCT00085436 2018-06-26

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

Phase 2 Completed

18 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00913913 2015-12-01

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Phase 2 Terminated

8 enrolled 10 charts

Carcinoma, Renal Cell